Claeys KG (2020) Congenital myopathies: an update. Dev Med Child Neurol 62:297–302. https://doi.org/10.1111/dmcn.14365
Laitila J, Wallgren-Pettersson C (2021) Recent advances in nemaline myopathy. Neuromuscul Disord 31:955–967. https://doi.org/10.1016/j.nmd.2021.07.012
Malfatti E, Romero NB (2016) Nemaline myopathies: state of the art. Rev Neurol (Paris) 172:614–619. https://doi.org/10.1016/j.neurol.2016.08.004
Carvalho AAS, Lacene E, Brochier G, Labasse C, Madelaine A, Silva VGD et al (2018) Genetic mutations and demographic, clinical, and morphological aspects of myofibrillar myopathy in a french cohort. Genet Test Mol Biomarkers 22:374–383. https://doi.org/10.1089/gtmb.2018.0004
Evangelista T, Lornage X, Carlier PG, Bassez G, Brochier G, Chanut A et al (2020) A heterozygous mutation in the Filamin C gene causes an unusual nemaline myopathy with ring fibers. J Neuropathol Exp Neurol 79:908–914. https://doi.org/10.1093/jnen/nlaa052
Madigan NN, Polzin MJ, Cui G, Liewluck T, Alsharabati MH, Klein CJ et al (2021) Filamentous tangles with nemaline rods in MYH2 myopathy: a novel phenotype. Acta Neuropathol Commun 9:79. https://doi.org/10.1186/s40478-021-01168-9
Sewry CA, Wallgren-Pettersson C (2017) Myopathology in congenital myopathies. Neuropathol Appl Neurobiol 43:5–23. https://doi.org/10.1111/nan.12369
Naddaf E, Milone M, Kansagra A, Buadi F, Kourelis T (2019) Sporadic late-onset nemaline myopathy: clinical spectrum, survival, and treatment outcomes. Neurology 93:e298–e305. https://doi.org/10.1212/WNL.0000000000007777
Schnitzler LJ, Schreckenbach T, Nadaj-Pakleza A, Stenzel W, Rushing EJ, Van Damme P et al (2017) Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 cases. Orphanet J Rare Dis 12:86. https://doi.org/10.1186/s13023-017-0640-2
Tanboon J, Uruha A, Arahata Y, Dittmayer C, Schweizer L, Goebel HH et al (2021) Inflammatory features in sporadic late-onset nemaline myopathy are independent from monoclonal gammopathy. Brain Pathol 31:e12962. https://doi.org/10.1111/bpa.12962
Voermans NC, Benveniste O, Minnema MC, Lokhorst H, Lammens M, Meersseman W et al (2014) Sporadic late-onset nemaline myopathy with MGUS: long-term follow-up after melphalan and SCT. Neurology 83:2133–2139. https://doi.org/10.1212/WNL.0000000000001047
Sewry CA, Laitila JM, Wallgren-Pettersson C (2019) Nemaline myopathies: a current view. J Muscle Res Cell Motil 40:111–126. https://doi.org/10.1007/s10974-019-09519-9
Ranu N, Laitila J, Dugdale HF, Mariano J, Kolb JS, Wallgren-Pettersson C et al (2022) NEB mutations disrupt the super-relaxed state of myosin and remodel the muscle metabolic proteome in nemaline myopathy. Acta Neuropathol Commun 10:185. https://doi.org/10.1186/s40478-022-01491-9
Kao JC, Liewluck T, Milone M (2018) A novel ACTA1 mutation causing progressive facioscapuloperoneal myopathy in an adult. J Clin Neurosci 53:261–262. https://doi.org/10.1016/j.jocn.2018.04.044
Nicolau S, Liewluck T, Tracy JA, Laughlin RS, Milone M (2019) Congenital myopathies in the adult neuromuscular clinic: diagnostic challenges and pitfalls. Neurol Genet 5:e341. https://doi.org/10.1212/NXG.0000000000000341
De Ridder W, De Jonghe P, Straub V, Baets J (2021) High prevalence of sporadic late-onset nemaline myopathy in a cohort of whole-exome sequencing negative myopathy patients. Neuromuscul Disord 31:1154–1160. https://doi.org/10.1016/j.nmd.2021.04.010
Engel AG (1997) The muscle biopsy. In: Engel AF-A, C (ed) Myology 2nd edition edn. McGraw-Hill, City, pp 822–831
Arneson-Wissink PC, Ducharme AM, Doles JD (2020) A novel transplantable model of lung cancer-associated tissue loss and disrupted muscle regeneration. Skelet Muscle 10:6. https://doi.org/10.1186/s13395-020-00225-6
Dubey D, Beecher G, Hammami MB, Knight AM, Liewluck T, Triplett J et al (2022) Identification of caveolae-associated protein 4 autoantibodies as a biomarker of immune-mediated rippling muscle disease in adults. JAMA Neurol 79:808–816. https://doi.org/10.1001/jamaneurol.2022.1357
Dasgupta A, Shukla SK, Vernucci E, King RJ, Abrego J, Mulder SE et al (2020) SIRT1-NOX4 signaling axis regulates cancer cachexia. J Exp Med. https://doi.org/10.1084/jem.20190745
Dasgupta A, Arneson-Wissink PC, Schmitt RE, Cho DS, Ducharme AM, Hogenson TL et al (2022) Anticachectic regulator analysis reveals Perp-dependent antitumorigenic properties of 3-methyladenine in pancreatic cancer. JCI Insight. https://doi.org/10.1172/jci.insight.153842
Ayers-Ringler JR, Oliveros A, Qiu Y, Lindberg DM, Hinton DJ, Moore RM et al (2016) Label-free proteomic analysis of protein changes in the striatum during chronic ethanol use and early withdrawal. Front Behav Neurosci 10:46. https://doi.org/10.3389/fnbeh.2016.00046
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545–15550. https://doi.org/10.1073/pnas.0506580102
Dasari S, Theis JD, Vrana JA, Meureta OM, Quint PS, Muppa P et al (2015) Proteomic detection of immunoglobulin light chain variable region peptides from amyloidosis patient biopsies. J Proteome Res 14:1957–1967. https://doi.org/10.1021/acs.jproteome.5b00015
Kourelis TV, Dasari S, Theis JD, Ramirez-Alvarado M, Kurtin PJ, Gertz MA et al (2017) Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light-chain amyloidosis by mass spectrometry. Blood 129:299–306. https://doi.org/10.1182/blood-2016-10-743997
Tabb DL, Fernando CG, Chambers MC (2007) MyriMatch: highly accurate tandem mass spectral peptide identification by multivariate hypergeometric analysis. J Proteome Res 6:654–661. https://doi.org/10.1021/pr0604054
Bodi K, Prokaeva T, Spencer B, Eberhard M, Connors LH, Seldin DC (2009) AL-Base: a visual platform analysis tool for the study of amyloidogenic immunoglobulin light chain sequences. Amyloid 16:1–8. https://doi.org/10.1080/13506120802676781
Lefranc MP, Lefranc G (2019) IMGT((R)) and 30 Years of Immunoinformatics insight in antibody V and C domain structure and function. Antibodies (Basel). https://doi.org/10.3390/antib8020029
Ma ZQ, Dasari S, Chambers MC, Litton MD, Sobecki SM, Zimmerman LJ et al (2009) IDPicker 2.0: Improved protein assembly with high discrimination peptide identification filtering. J Proteome Res 8:3872–3881. https://doi.org/10.1021/pr900360j
Li M, Gray W, Zhang H, Chung CH, Billheimer D, Yarbrough WG et al (2010) Comparative shotgun proteomics using spectral count data and quasi-likelihood modeling. J Proteome Res 9:4295–4305. https://doi.org/10.1021/pr100527g
Becker N, Moore SA, Jones KA (2022) The inflammatory pathology of dysferlinopathy is distinct from calpainopathy, Becker muscular dystrophy, and inflammatory myopathies. Acta Neuropathol Commun 10:17. https://doi.org/10.1186/s40478-022-01320-z
Hamanaka K, Miyatake S, Koshimizu E, Tsurusaki Y, Mitsuhashi S, Iwama K et al (2019) RNA sequencing solved the most common but unrecognized NEB pathogenic variant in Japanese nemaline myopathy. Genet Med 21:1629–1638. https://doi.org/10.1038/s41436-018-0360-6
Laflamme N, Lace B, Thonta Setty S, Rioux N, Labrie Y, Droit A et al (2021) A Homozygous deep intronic mutation alters the splicing of nebulin gene in a patient with nemaline myopathy. Front Neurol 12:660113. https://doi.org/10.3389/fneur.2021.660113
Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR et al (2006) Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 354:1362–1369. https://doi.org/10.1056/NEJMoa054494
Malfatti E, Lehtokari VL, Bohm J, De Winter JM, Schaffer U, Estournet B et al (2014) Muscle histopathology in nebulin-related nemaline myopathy: ultrastrastructural findings correlated to disease severity and genotype. Acta Neuropathol Commun 2:44. https://doi.org/10.1186/2051-5960-2-44
Chahin N, Selcen D, Engel AG (2005) Sporadic late onset nemaline myopathy. Neurology 65:1158–1164. https://doi.org/10.1212/01.wnl.0000180362.90078.dc
Zhao B, Dai T, Zhao D, Ma X, Zhao C, Li L et al (2022) Clinicopathologic profiles of sporadic late-onset nemaline myopathy: practical importance of anti-alpha-actinin immunostaining. Neurol Neuroimmunol Neuroinflamm. https://doi.org/10.1212/NXI.0000000000001184
Laing NG, Wilton SD, Akkari PA, Dorosz S, Boundy K, Kneebone C et al (1995) A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy. Nat Genet 9:75–79. https://doi.org/10.1038/ng0195-75
Malfatti E, Schaeffer U, Chapon F, Yang Y, Eymard B, Xu R et al (2013) Combined cap disease and nemaline myopathy in the same patient caused by an autosomal dominant mutation in the TPM3 gene. Neuromuscul Disord 23:992–997. https://doi.org/10.1016/j.nmd.2013.07.003
Zambon AA, Abel F, Linnane B, O’Rourke D, Phadke R, Sewry CA et al (2022) Troponin-T type 1 (TNNT1)-related nemaline myopathy: unique respiratory phenotype and muscle pathology findings. Neuromuscul Disord 32:245–254. https://doi.org/10.1016/j.nmd.2022.01.014
Vandebrouck A, Domazetovska A, Mokbel N, Cooper ST, Ilkovski B, North KN (2010) In vitro analysis of rod composition and actin dynamics in inherited myopathies. J Neuropathol Exp Neurol 69:429–441. https://doi.org/10.1097/NEN.0b013e3181d892c6
Naddaf E, Dasari S, Selcen D, Charlesworth MC, Johnson KL, Mauermann ML et al (2022) Proteomic profiling of sporadic late-onset nemaline myopathy. Ann Clin Transl Neurol 9:391–402. https://doi.org/10.1002/acn3.51527
Kley RA, Leber Y, Schrank B, Zhuge H, Orfanos Z, Kostan J et al (2021) FLNC-associated myofibrillar myopathy: new clinical, functional, and proteomic data. Neurol Genet 7:e590. https://doi.org/10.1212/NXG.0000000000000590
留言 (0)